J. Andrew Skirvin
Associate Clin. Professor
Department: Department of Pharmacy Practice
Department 2: School of Pharmacy
Office: 140 The Fenway, R220
 
Résumé/CV

Phone: 617-373-4166
Fax: 617-373-7655
Email: j.skirvin@neu.edu

 
 
Education:
Oregon State University, Bachelor of Science in Pharmacy, 1992
University of Texas at Austin, Doctor of Pharmacy, 1995
Southwest Veterans Hospital, Audie Murphy Division, Oncology Speciaility Pharmacy Residency 1995-1996.

Certification: Board Certified Oncology Pharmacist 2000

Specializations: Hematology/Oncology Pharmacy Practice

Research:
Supportive care for the cancer patient including: pain management, nausea & vomiting, neutropenic fever, long term complications, growth factor support, etc.

Public Service: Service to cancer patients through my clinical practice site.

Publications:
Skirvin JA, Patel P. Update on FDA approvals and selected investigational agents. Newsletter, Hematology/Oncology Pharmacy Association, HOPA News, Winter 2006;5-7.
Skirvin JA. Chapter 44, Thrombocytopenia. In Tisdale JE, Miller, DA, editors. Drug-Induced Diseases, prevention, detection, and management. American Society of Health-System Pharmacists. Bethesda, MD; 2005:649-60.
Skirvin JA, Lichtman SM: Pharmacokinetic considerations of oral chemotherapy in elderly cancer patients. Drugs Aging 2002;19:25-42.
Skirvin JA. Melanoma: current detection and management strategies. US Pharmacist Health-System edition 2001;Supplement September:17-28.
Skirvin JA, Vemulapalli S, Lichtman SM: Pharmacology of antineoplastic agents in older cancer patients. Oncology Spectrum 2001;2:404-13.
Skirvin JA, Gorowski E, D’Olimpio JT. Promoting in-patient pain management at a university hospital with comprehensive needs assessment. Proceedings of ASCO 2001;20:304b.
Lichtman S, Skirvin JA. Pharmacology of antineoplastic agents in older cancer patients. Oncology 2000;14:1743-55
Skirvin JA, D’Olimpio JT, Gorowski E. Pain assessment survey of adult oncology admissions: a performance improvement project (Abstract). Proceedings of ASCO 2000,19:640a.
Skirvin JA. Topotecan. CancerRX in Cancer Therapeutics 1999;2:121-5.
Stirling A, Kao E, Skirvin J, Hirsch B. Impact of pharmacist-run aminoglycoside once daily program in a tertiary teaching institution (Abstract). Pharmacotherapy 1999;19:517.
Skirvin JA, Lichtman SM, Negri A, et al. Pharmacist intervention program monitoring filgrastim use in hospitalized patients (Abstract 2252). Proceedings of ASCO 1999;18:583a.
Taibbi R, Kao E, Skirvin JA, et al. Development of an performance improvement program to increase the safety of chemotherapy administration (Abstract 2343). Proceedings of ASCO 1999;18:607a.
Stirling A, Kao E, Skirvin J, Hirsch B. Impact of pharmacist-run aminoglycoside once daily program in a tertiary teaching institution (Abstract). Pharmacotherapy 1999;19:517.
Castanheira D, Marzella M, Skirvin JA. Administration of filgrastim in two patients with drug-induced agranulocytosis. Pharmacotherapy 1998;18:1347-51.
Skirvin JA, Relias V. Topoisomerase Inhibitors: 2. Irinotecan. J Oncol Pharm Practice 1998;4:103-16.
Skirvin JA, Valley AW, Relias V, Morris AK. 6-Mercaptopurine hepatoxicity during acute lymphocytic leukemia maintenance therapy. J Oncol Pharm Practice 1998;4:117-20.
Skirvin JA, Brocavich JM. IV Immunoglobulin Therapy in Immunosuppressed Patients. US Pharmacist health-system edition 1998;23:HS-37-48.
Relias V, Skirvin JA. Topoisomerase I inhibitors: 1. Topotecan. J Oncol Pharm Practice 1997;3:173-85.
Skirvin JA, consultant. Nurse ProCalc: make-a-test, version 2.0. Microsoft Windows 3.1, Windows 95 compatible. In: Brown P, Brown ED. Nurse ProCalc: make-a-test, version 2.0. Chapel Hill: Professional Development Software, 1997, Updated in 2005.
Skirvin JA. Kaposi’s sarcoma: new treatment options. Newsletter, Long Island Society of Hospital Pharmacists 1997 April;27(8):1-2.
Skirvin JA, Relias V, Koeller J. Long-term sequelae of chemotherapy. Highlights in Oncology Practice 1996;14:26-34.
Skirvin JA. Morphine use in renal failure. Newsletter, Long Island Society of Hospital Pharmacists 1996 September;27(1):1.
Skirvin A. New Drug: Gabapentin (newsletter). Current Therapeutic Issues 1994 November; 9(1):1.
Skirvin A, Knodel LC. Efficacy of desipramine in attention deficit hyperactivity disorder (Drug Consult). In: Gelman CR, Rumack BH, editors. Drugdex® Information System. Denver: Micromedex, Inc., 1994.
Skirvin A, Kraynak MA. Role of cisapride in the therapy of chronic intestinal pseudo-obstruction in pediatrics (Drug Consult). In: Gelman CR, Rumack BH, editors. Drugdex® Information System. Denver: Micromedex, Inc., 1994.
Wanke LA, Skirvin JA. Physostigmine Therapy of Intrathecal Baclofen Overdose (Drug Consult). In: Gelman CR, Rumack BH, editors. Drugdex® Information System. Denver: Micromedex, Inc., 1992.


 
[Back to Directory]
 
Manage